Warning! GuruFocus detected
2 Severe warning signs
with PRE.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Prenetics Global Ltd
NAICS : 621512
SIC : 8734
ISIN : BMG686031698
Share Class Description:
PRE: Class ADescription
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.6 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.05 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -39.7 | |||||
| 3-Year EBITDA Growth Rate | -183.1 | |||||
| 3-Year FCF Growth Rate | -17.6 | |||||
| 3-Year Book Growth Rate | 59.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.67 | |||||
| 9-Day RSI | 22.24 | |||||
| 14-Day RSI | 27.03 | |||||
| 3-1 Month Momentum % | -5.58 | |||||
| 6-1 Month Momentum % | 22.25 | |||||
| 12-1 Month Momentum % | 13.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | |||||
| Quick Ratio | 1.22 | |||||
| Cash Ratio | 0.87 | |||||
| Days Inventory | 134.83 | |||||
| Days Sales Outstanding | 64.07 | |||||
| Days Payable | 110.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.2 | |||||
| Shareholder Yield % | 5.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.43 | |||||
| Operating Margin % | -168.25 | |||||
| Net Margin % | -183.52 | |||||
| FCF Margin % | -57.42 | |||||
| ROE % | -23.52 | |||||
| ROA % | -18.87 | |||||
| ROIC % | -23.07 | |||||
| 3-Year ROIIC % | -42.84 | |||||
| ROC (Joel Greenblatt) % | -746.19 | |||||
| ROCE % | -23.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.93 | |||||
| PB Ratio | 0.28 | |||||
| Price-to-Tangible-Book | 0.38 | |||||
| EV-to-EBIT | -0.36 | |||||
| EV-to-EBITDA | -0.36 | |||||
| EV-to-Revenue | 0.69 | |||||
| EV-to-FCF | -1.2 | |||||
| Price-to-Net-Current-Asset-Value | 4.14 | |||||
| Earnings Yield (Greenblatt) % | -277.78 | |||||
| FCF Yield % | -29.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PRE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Prenetics Global Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 25.561 | ||
| EPS (TTM) ($) | -3.99 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 57.75 | ||
| 14-Day RSI | 27.03 | ||
| 14-Day ATR ($) | 0.25437 | ||
| 20-Day SMA ($) | 4.661049 | ||
| 12-1 Month Momentum % | 13.53 | ||
| 52-Week Range ($) | 2.85 - 7.838 | ||
| Shares Outstanding (Mil) | 12.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Prenetics Global Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Prenetics Global Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Prenetics Global Ltd Frequently Asked Questions
What is Prenetics Global Ltd(PRE)'s stock price today?
The current price of PRE is $4.06. The 52 week high of PRE is $7.84 and 52 week low is $2.85.
When is next earnings date of Prenetics Global Ltd(PRE)?
The next earnings date of Prenetics Global Ltd(PRE) is 2025-04-02 Est..
Does Prenetics Global Ltd(PRE) pay dividends? If so, how much?
Prenetics Global Ltd(PRE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers